News
Stay up to date on the latest crypto trends with our expert, in-depth coverage.
1Bitget UEX Daily | Trump Does Not Rule Out Sending Troops to Iran; Iran Closes Strait of Hormuz, Oil Prices Soar; Drone and Space Stocks Rise Collectively (2026/03/03)2Bitcoin slide slowing, but bear market still in play: Analysts3Research Report｜In-Depth Analysis and Market Cap of Opinion Labs (OPN)
Ethereum's Vitalik Buterin: build 'sanctuary tech,' forget emulating Apple or Google
The Block·2026/03/03 21:39
Anthropic's Tool Launch: A Strategic Boost for Technology Shares
101 finance·2026/03/03 21:27
A16z Crypto updates Jolt zkVM, challenges loose use of ‘ZK’ label
The Block·2026/03/03 21:15
Hasbro Relocates Headquarters: Savvy Financial Decision or Purposeful Organizational Shift?
101 finance·2026/03/03 21:03
Pi Network price prediction: $0.20 still in play as 3 signals align
AMBCrypto·2026/03/03 21:03
Mastercard and Visa strike agreements to boost stablecoins
101 finance·2026/03/03 21:00
Profit Realization and Guidance Adjustments: Navigating Expectation Gaps in Consumer Staples
101 finance·2026/03/03 20:57
XRP Under Pressure Despite 24 % Surge In Trading Volume
Cointribune·2026/03/03 20:57
38% of altcoins in critical zone according to CryptoQuant
Cointribune·2026/03/03 20:57
Trump Fears Iran’s Leadership Could Remain ‘Equally Problematic’ Following Conflict
101 finance·2026/03/03 20:51
Flash
21:42
According to the latest documents disclosed by the U.S. Securities and Exchange Commission (SEC), Mira Pharma (stock code: MIRA) announced that its candidate drug Ketamir-2 did not observe clinically significant dissociative or psychosis-inducing side effects in Phase I clinical trials.The results of this trial mark a significant advancement in the safety profile of Ketamir-2, paving the way for its subsequent clinical development. The company emphasized that this discovery is expected to drive further exploration of the drug in therapeutic applications.
21:42
Moderna, Inc. (MRNA) has recently updated its financial outlook, announcing an adjustment of its expected cash and cash equivalents at the end of 2026 to a range of $4.5 billion to $5.0 billion.This revised forecast reflects the company's reassessment of its future cash flow situation.
21:38
Industry Weekly Report: US API Crude Oil Inventories Increased by Over 5.6 Million Barrels Last WeekLast week, API Cushing crude oil inventories increased by 1.54 million barrels, previous value was +1.792 million barrels. Last week, API refined gasoline inventories decreased by 3.286 million barrels (previous value -1.535 million barrels), and distillate inventories increased by 0.516 million barrels (previous value -2.771 million barrels).
News